株探米国株
日本語 英語
エドガーで原本を確認する
false000070754900007075492025-07-302025-07-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 30, 2025
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware   0-12933   94-2634797
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐


Table of Contents
 
Item 2.02.    Results of Operations and Financial Condition
Item 9.01.    Financial Statements and Exhibits
SIGNATURES
EX-99.1



 Item 2.02. Results of Operations and Financial Condition
On July 30, 2025, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 29, 2025, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 30, 2025
LAM RESEARCH CORPORATION
(Registrant)
  /s/ Douglas R. Bettinger
  Douglas R. Bettinger
  Executive Vice President and Chief Financial Officer
  (Principal Financial Officer)
 


EX-99.1 2 lrcx_exhibitx991xq4x2025.htm EX-99.1 Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended June 29, 2025
FREMONT, Calif., July 30, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 29, 2025 (the “June 2025 quarter”).
Highlights for the June 2025 quarter were as follows:
•Revenue of $5.17 billion.
•U.S. GAAP gross margin of 50.1%, U.S. GAAP operating income as a percentage of revenue of 33.7%, and U.S. GAAP diluted EPS of $1.35.
•Non-GAAP gross margin of 50.3%, non-GAAP operating income as a percentage of revenue of 34.4%, and non-GAAP diluted EPS of $1.33.
Key Financial Data for the Quarters Ended
June 29, 2025 and March 30, 2025
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
  June 2025 March 2025 Change Q/Q
Revenue $ 5,171,393  $ 4,720,175  +9.6%
Gross margin as percentage of revenue 50.1  % 49.0  % + 110 bps
Operating income as percentage of revenue 33.7  % 33.1  % + 60 bps
Diluted EPS $ 1.35  $ 1.03  +31.1%
Non-GAAP
  June 2025 March 2025 Change Q/Q
Revenue $ 5,171,393  $ 4,720,175  +9.6%
Gross margin as percentage of revenue 50.3  %   49.0  % + 130 bps
Operating income as percentage of revenue 34.4  %   32.8  % + 160 bps
Diluted EPS $ 1.33    $ 1.04  +27.9%
U.S. GAAP Financial Results
For the June 2025 quarter, revenue was $5,171 million, gross margin was $2,590 million, or 50.1% of revenue, operating expenses were $849 million, operating income was 33.7% of revenue, and net income was $1,720 million, or $1.35 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,720 million, gross margin of $2,314 million, or 49.0% of revenue, operating expenses of $752 million, operating income of 33.1% of revenue, and net income of $1,331 million, or $1.03 per diluted share, for the quarter ended March 30, 2025 (the “March 2025 quarter”).
Non-GAAP Financial Results
For the June 2025 quarter, non-GAAP gross margin was $2,601 million, or 50.3% of revenue, non-GAAP operating expenses were $822 million, non-GAAP operating income was 34.4% of revenue, and non-GAAP net income was $1,698 million, or $1.33 per diluted share. This compares to non-GAAP gross margin of $2,312 million, or 49.0% of revenue, non-GAAP operating expenses of $763 million, non-GAAP operating income of 32.8% of revenue, and non-GAAP net income of $1,336 million, or $1.04 per diluted share, for the March 2025 quarter.
“Lam delivered another solid quarter, highlighted by strong gross margins and record EPS,” said Tim Archer, Lam Research's President and Chief Executive Officer. “With deposition and etch criticality intensifying in the AI era, we are executing on our long-term strategic initiatives and leveraging our differentiated product portfolio to position Lam for outperformance.”








Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances increased to $6.4 billion at the end of the June 2025 quarter compared to $5.5 billion at the end of the March 2025 quarter. The increase was primarily driven by cash generated from operating activities, partially offset by cash deployed for capital return activities and capital expenditures during the quarter.
Deferred revenue at the end of the June 2025 quarter increased to $2,681 million compared to $2,011 million as of the end of the March 2025 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $342 million as of June 29, 2025 and $587 million as of March 30, 2025.
Revenue
The geographic distribution of revenue during the June 2025 quarter is shown in the following table:
Region Revenue
China 35%
Korea 22%
Taiwan 19%
Japan 14%
United States 6%
Southeast Asia 2%
Europe 2%
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended
June 29,
2025
March 30,
2025
June 30,
2024
(In thousands)
Systems revenue $ 3,437,625  $ 3,035,276  $ 2,169,885 
Customer support-related revenue and other 1,733,768  1,684,899  1,701,622 
$ 5,171,393  $ 4,720,175  $ 3,871,507 
Systems revenue includes sales of new leading-edge equipment in deposition, etch and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 28, 2025, Lam is providing the following guidance:
U.S. GAAP Reconciling Items Non-GAAP
Revenue $5.20 Billion +/- $300 Million $5.20 Billion +/- $300 Million
Gross margin as a percentage of revenue 49.9% +/- 1% $ 2.7  Million 50.0% +/- 1%
Operating income as a percentage of revenue 33.9% +/- 1% $ 3.2  Million 34.0% +/- 1%
Net income per diluted share $1.20 +/- $0.10 $ 3.7  Million $1.20 +/- $0.10
Diluted share count 1.27 Billion 1.27 Billion
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:



•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $2.7 million.
•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3.2 million.
•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3.2 million; amortization of debt discounts, $0.7 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.7 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2025 and March 2025 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. In addition, the June 2025 quarter excludes the income tax benefit on conclusion of certain tax matters related to a prior business combination.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; the significance of deposition and etch in the AI era; our execution on our long-term strategic initiatives; the competitive positioning of our product portfolio and overall business; and our prospects for outperformance. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 30, 2024, and our quarterly report on Form 10–Q for the fiscal quarter ended March 30, 2025. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Consolidated Financial Tables Follow.
 ###





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
  Three Months Ended Twelve Months Ended
  June 29,
2025
March 30,
2025
June 30,
2024
June 29,
2025
June 30,
2024
(unaudited) (unaudited) (unaudited) (unaudited) (1)
Revenue $ 5,171,393  $ 4,720,175  $ 3,871,507  $ 18,435,591  $ 14,905,386 
Cost of goods sold 2,581,684  2,406,489  2,026,133  9,456,532  7,809,220 
Restructuring charges, net - cost of goods sold —  —  5,276  —  43,375 
Total cost of goods sold 2,581,684  2,406,489  2,031,409  9,456,532  7,852,595 
Gross margin 2,589,709  2,313,686  1,840,098  8,979,059  7,052,791 
Gross margin as a percent of revenue 50.1  % 49.0  % 47.5  % 48.7  % 47.3  %
Research and development 580,178  525,904  497,829  2,096,387  1,902,444 
Selling, general and administrative 268,403  226,023  216,477  981,704  868,247 
Restructuring charges, net - operating expenses —  —  (768) —  18,187 
Total operating expenses 848,581  751,927  713,538  3,078,091  2,788,878 
Operating income 1,741,128  1,561,759  1,126,560  5,900,968  4,263,913 
Operating income as a percent of revenue 33.7  % 33.1  % 29.1  % 32.0  % 28.6  %
Other income (expense), net 37,853  (25,035) 27,796  57,161  96,309 
Income before income taxes 1,778,981  1,536,724  1,154,356  5,958,129  4,360,222 
Income tax expense (58,893) (206,057) (134,074) (599,912) (532,450)
Net income $ 1,720,088  $ 1,330,667  $ 1,020,282  $ 5,358,217  $ 3,827,772 
Net income per share:
Basic $ 1.35  $ 1.04  $ 0.78  $ 4.17  $ 2.91 
Diluted $ 1.35  $ 1.03  $ 0.78  $ 4.15  $ 2.90 
Number of shares used in per share calculations:
Basic 1,274,279  1,283,779  1,306,333  1,286,101  1,314,102 
Diluted 1,276,933  1,288,100  1,311,118  1,290,142  1,319,949 
Cash dividend declared per common share $ 0.23  $ 0.23  $ 0.20  $ 0.92  $ 0.80 
(1) Derived from audited financial statements














 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
June 29,
2025
March 30,
2025
June 30,
2024
(unaudited) (unaudited) (1)
ASSETS
Cash and cash equivalents $ 6,390,659  $ 5,450,718  $ 5,847,856 
Accounts receivable, net 3,378,071  3,228,182  2,519,250 
Inventories 4,307,991  4,463,275  4,217,924 
Prepaid expenses and other current assets 440,274  318,147  298,190 
Total current assets 14,516,995  13,460,322  12,883,220 
Property and equipment, net 2,428,744  2,372,203  2,154,518 
Goodwill and intangible assets 1,808,685  1,795,248  1,765,073 
Other assets 2,590,836  2,340,537  1,941,917 
Total assets $ 21,345,260  $ 19,968,310  $ 18,744,728 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations $ 754,311  $ 754,306  $ 504,814 
Other current liabilities 5,814,114  4,735,539  3,833,624 
Total current liabilities 6,568,425  5,489,845  4,338,438 
Long-term debt and finance lease obligations 3,730,194  3,730,034  4,478,520 
Income taxes payable 603,412  690,660  813,304 
Other long-term liabilities 581,610  546,666  575,012 
Total liabilities 11,483,641  10,457,205  10,205,274 
Stockholders’ equity (2) 9,861,619  9,511,105  8,539,454 
Total liabilities and stockholders’ equity $ 21,345,260  $ 19,968,310  $ 18,744,728 
 
(1) Derived from audited financial statements
(2)
Common shares issued and outstanding were 1,268,740 as of June 29, 2025, 1,282,957 as of March 30, 2025, and 1,303,769 as of June 30, 2024
 





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
  Three Months Ended Twelve Months Ended
  June 29,
2025
March 30,
2025
June 30,
2024
June 29,
2025
June 30,
2024
(unaudited) (unaudited) (unaudited) (unaudited) (1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 1,720,088  $ 1,330,667  $ 1,020,282  $ 5,358,217  $ 3,827,772 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 98,439  97,343  88,357  386,277  359,699 
Deferred income taxes (151,679) (19,992) (61,375) (363,247) (198,981)
Equity-based compensation expense 94,286  87,115  79,092  343,371  293,058 
Other, net 14,240  1,654  (3,999) 6,845  10,243 
Changes in operating assets and liabilities 778,814  (188,124) (259,927) 441,801  360,478 
Net cash provided by operating activities 2,554,188  1,308,663  862,430  6,173,264  4,652,269 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (172,191) (288,058) (100,748) (759,186) (396,670)
Net maturities and sale of available-for-sale securities —  —  —  —  37,766 
Other, net 42,940  (4,857) (865) 51,094  (11,710)
Net cash used for investing activities (129,251) (292,915) (101,613) (708,092) (370,614)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease obligations and payments for debt issuance costs (1,485) (504,037) (949) (507,488) (256,104)
Treasury stock purchases, including excise tax payments (1,292,277) (435,321) (373,550) (3,422,321) (2,842,807)
Dividends paid (295,207) (295,716) (261,462) (1,149,542) (1,018,915)
Reissuance of treasury stock related to employee stock purchase plan 79,556  —  66,885  140,113  119,966 
Proceeds from issuance of common stock 696  1,993  2,796  2,452  15,553 
Other, net (820) 526  (7,871) 143  (13,543)
Net cash used for financing activities (1,509,537) (1,232,555) (574,151) (4,936,643) (3,995,850)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 29,284  2,380  (9,616) 28,324  (22,374)
Net change in cash, cash equivalents, and restricted cash 944,684  (214,427) 177,050  556,853  263,431 
Cash, cash equivalents, and restricted cash at beginning of period (2) 5,462,972  5,677,399  5,673,753  5,850,803  5,587,372 
Cash, cash equivalents, and restricted cash at end of period (2) $ 6,407,656  $ 5,462,972  $ 5,850,803  $ 6,407,656  $ 5,850,803 
(1) Derived from audited financial statements
(2) Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets




 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
June 29,
2025
March 30,
2025
Revenue $ 5,171,393  $ 4,720,175 
Gross margin $ 2,600,952  $ 2,312,391 
Gross margin as percentage of revenue 50.3  % 49.0  %
Operating expenses $ 822,375  $ 763,336 
Operating income $ 1,778,577  $ 1,549,055 
Operating income as a percentage of revenue 34.4  % 32.8  %
Net income $ 1,697,716  $ 1,336,006 
Net income per diluted share $ 1.33  $ 1.04 
Shares used in per share calculation - diluted 1,276,933  1,288,100 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
June 29,
2025
March 30,
2025
U.S. GAAP net income $ 1,720,088  $ 1,330,667 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 2,687  2,687 
Elective deferred compensation ("EDC") related liability valuation increase (decrease) - cost of goods sold 8,556  (3,982)
EDC related liability valuation increase (decrease) - research and development 15,401  (7,168)
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 538  538 
EDC related liability valuation increase (decrease) - selling, general and administrative 10,267  (4,779)
Amortization of note discounts - other income (expense), net 689  759 
(Gain) loss on EDC related asset - other income (expense), net (34,102) 16,903 
Net income tax (benefit) expense on non-GAAP items (1,668) 381 
Income tax benefit on the conclusion of certain tax matters (24,740) — 
Non-GAAP net income $ 1,697,716  $ 1,336,006 
Non-GAAP net income per diluted share $ 1.33  $ 1.04 
U.S. GAAP net income per diluted share $ 1.35  $ 1.03 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 1,276,933  1,288,100 




 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
June 29,
2025
March 30,
2025
U.S. GAAP gross margin $ 2,589,709  $ 2,313,686 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 2,687  2,687 
EDC related liability valuation increase (decrease) 8,556  (3,982)
Non-GAAP gross margin $ 2,600,952  $ 2,312,391 
U.S. GAAP gross margin as a percentage of revenue 50.1  % 49.0  %
Non-GAAP gross margin as a percentage of revenue 50.3  % 49.0  %
U.S. GAAP operating expenses $ 848,581  $ 751,927 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations (538) (538)
EDC related liability valuation (increase) decrease (25,668) 11,947 
Non-GAAP operating expenses $ 822,375  $ 763,336 
U.S. GAAP operating income $ 1,741,128  $ 1,561,759 
Non-GAAP operating income $ 1,778,577  $ 1,549,055 
U.S. GAAP operating income as percent of revenue 33.7  % 33.1  %
Non-GAAP operating income as a percent of revenue 34.4  % 32.8  %
 
Lam Research Corporation Contact:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com